Francoise Pieri - Areva SA Executive
Executive
Mrs.Francoise Pieri has served as Director Representative of the Employees of Areva S.A. since October 31, 2014. Mrs.Francoise Pieri was a secretary with the Testing Department of SGN from1987 to1989. From1990 to2010, she held various secretarial positions at Socatri. Since October2010, Mrs.Francoise Pieri was an integrated management system specialist with AREVA NC. Within the Company, she was Member of the Supervisory Board Employee Representative between June 21, 2012 and October 31, 2014. Member of the Audit and Ethics Committee. Member of the AREVA TA Working Group. since 2014.
Age | 48 |
Tenure | 10 years |
Phone | 33 1 34 96 00 00 |
Web | http://www.areva.com |
Areva SA Management Efficiency
The company has return on total asset (ROA) of (1.52) % which means that it has lost $1.52 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 2.0 %, meaning that it generated $2.0 on every $100 dollars invested by stockholders. Areva SA's management efficiency ratios could be used to measure how well Areva SA manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 4.01 B in total debt with debt to equity ratio (D/E) of 1.95, which is about average as compared to similar companies. Areva SA has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Areva SA until it has trouble settling it off, either with new capital or with free cash flow. So, Areva SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Areva SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Areva to invest in growth at high rates of return. When we think about Areva SA's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Steve Alexander | Shoe Carnival | N/A | |
Antonoaldo Neves | Azul SA | 41 | |
Michael II | Mesa Air Group | N/A | |
Henri Courpron | Azul SA | 56 | |
Neng Li | Azul SA | 37 | |
Stewart Smith | Azul SA | 69 | |
Deborah Hannah | Shoe Carnival | N/A | |
Angela Brawdy | Shoe Carnival | N/A | |
Brian Davis | Sun Country Airlines | 43 | |
Eric Levenhagen | Sun Country Airlines | 42 | |
Carolyn Trabuco | Azul SA | 51 | |
Jason Ward | Azul SA | N/A | |
Javier Suarez | Global Crossing Airlines | N/A | |
Muge Dogan | Nike Inc | N/A | |
Abhi Shah | Azul SA | 46 | |
Mark Bocchi | Alaska Air Group | N/A | |
Alexandre Malfitani | Azul SA | 52 | |
Jordi Porcel | Global Crossing Airlines | N/A | |
Sergio Pinto | Azul SA | 55 | |
Matt Grady | Alaska Air Group | N/A | |
Jeff Walker | Global Crossing Airlines | N/A |
Management Performance
Return On Equity | 2.0 | |||
Return On Asset | -1.52 |
Areva SA Leadership Team
Elected by the shareholders, the Areva SA's board of directors comprises two types of representatives: Areva SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Areva. The board's role is to monitor Areva SA's management team and ensure that shareholders' interests are well served. Areva SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Areva SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Francois Nogue, Senior Executive Vice President of Human Resources, Member of the Executive Management Board | ||
Alain Vandercruyssen, Senior Executive Vice President of the Dismantling and Services BU, Member of the Executive Committee | ||
Pascal Aubret, Senior Executive Vice President of the Recycling BU, Member of the Executive Committee | ||
Frederic Agostini, Senior Executive Vice President of the Logistics BU, Member of the Executive Committee | ||
Daniel Verwaerde, Vice Chairman of the Board of Directors | ||
Guylaine Saucier, Independent Member of the Supervisory Board | ||
Dominique Mockly, Senior Executive Vice President - Back End Business Group | ||
Pierre Blayau, Chairman of the Supervisory Board | ||
Veronique Rouzaud, Senior Executive Vice President - Human Resources, Member of the Executive Management Board | ||
Magali Smets, Secretary of the Executive Management Board | ||
Remy Autebert, Senior Executive Vice President - Asia Region and Executive Director for Reorganization of the International Commercial Function, Member of the Executive Management Board | ||
Francoise Pieri, Member of the Supervisory Board - Employee Representative | ||
LouisFrancois Durret, Senior Executive Vice President - Renewable Energies Business Group | ||
Antoine Troesch, Senior Executive Vice President of the Chemistry/Enrichment BU, Member of the Executive Committee | ||
Francois David, Independent Member of the Supervisory Board | ||
Christophe Gegout, Member of the Supervisory Board - Representative of CEA | ||
JeanMichel Lang, Employee Representative on the Board of Directors | ||
Jacques Gerault, Senior Executive Vice President - Public Affairs, Member of the Executive Management Board | ||
Agnes Lemarchand, Independent Member of the Supervisory Board | ||
Sophie Boissard, Member of the Supervisory Board | ||
Olivier Wantz, Sr. Executive VP of Mining and Front End Bus. Groups | ||
Christian Masset, Director - Representative of the French State | ||
Jacques Peythieu, Senior Executive Vice President of the Mining BU, Member of the Executive Committee | ||
Guillaume Dureau, Senior Executive Vice President - Front End Business Group | ||
David Azema, Member of the Supervisory Board - Representative of the French Government | ||
Stephane Lhopiteau, CFO | ||
Eric Chassard, Senior Executive Vice President - Engineering and Projects, Member of the Executive Management Board | ||
Bernard Fontana, Senior Executive Vice President Member of the Executive Board | ||
Philippe Knoche, CEO, Member of Executive Management Board and Director | ||
ODILE MATTE, Employee Representative on the Board of Directors | ||
MarieHelene Sartorius, Independent Director | ||
Bernard Bigot, Vice Chairman of the Supervisory Board | ||
Pierre Charreton, Chief Admin. Officer, General Counsel, Secretary, Member of Executive Management Board and Chairman of Risk Committee | ||
Philippe Varin, Chairman of the Board, Member of the Supervisory Board | ||
AnneMarie Choho, Senior Executive Vice President - Operations Support, Member of the Executive Management Board | ||
Pascal Faure, Member of the Supervisory Board - Representative of the French Government | ||
Pascale Sourisse, Independent director | ||
Alexis Zajdenweber, Member of the Board of Directors - Representative of the French State | ||
Tarik Choho, Senior Chief Commercial Officer, Member of the Executive Management Board | ||
Claude Imauven, Director | ||
Philippine Repaire, Vice President of Communication and Investor Relations | ||
Denis Morin, Director - Representative of the French State | ||
Philippe Samama, Senior Executive Vice President - Reactors and Services Business Group, Member of the Executive Management Board | ||
Manuel Lachaux, Vice President of Communication and Investor Relations | ||
Malak Tazi, Deputy Secretary of the Board of Directors | ||
Charles Hufnagel, Senior Executive Vice President - Communications, Member of the Executive Management Board | ||
Christian Barandas, Special Advisor to the CEO |
Areva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Areva SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 2.0 | |||
Return On Asset | -1.52 | |||
Profit Margin | 26.32 % | |||
Current Valuation | 9.14 B | |||
Shares Outstanding | 383.2 M | |||
Price To Earning | (2.61) X | |||
Price To Book | 0.88 X | |||
Price To Sales | 88.94 X | |||
Revenue | 22.35 M | |||
Gross Profit | (409 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Areva SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Areva SA's short interest history, or implied volatility extrapolated from Areva SA options trading.
Pair Trading with Areva SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Areva SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Areva SA will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Tenet Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenet Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenet Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenet Healthcare to buy it.
The correlation of Tenet Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenet Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenet Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenet Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Areva SA information on this page should be used as a complementary analysis to other Areva SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Areva Pink Sheet
If you are still planning to invest in Areva SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Areva SA's history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets |